Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nanoform and Boehringer Ingelheim execute master services agreement 2021-08-03 14:28
Jacobio Announces First Patient Dosed in Phase I/II Clinical Trial of KRAS G12C Inhibitor for Solid Tumor 2021-08-03 09:00
CStone announces positive registrational study of the first-in-class drug ivosidenib in Chinese patients with relapsed or refractory acute myeloid leukemia, and NDA has been accepted by the China NMPA and considered for Priority Review 2021-08-03 08:05
Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus 2021-08-03 08:00
Cardinal Health completes sale of Cordis business to Hellman & Friedman 2021-08-02 23:00
Cardinal Health completes sale of Cordis business to Hellman & Friedman 2021-08-02 23:00
SI Group Ranks in the Top 5 Percent for Global Corporate Social Responsibility 2021-08-02 22:33
Vision Impact Institute Applauds UN Resolution on Vision 2021-08-02 22:30
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate 2021-08-02 20:13
Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets 2021-08-02 18:45
ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO 2021-08-02 18:00
Bionomics Announces Plans to Conduct U.S. Initial Public Offering 2021-08-02 18:00
Hummingbird Bioscience Announces UK MHRA Approval for First-in-Human Phase 1 Trial of HMBD-001 in Advanced Cancers 2021-08-02 17:00
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines 2021-08-02 15:25
Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye® RLP 2021-08-02 14:28
Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia 2021-08-02 14:00
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic 2021-08-02 11:11
Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in Asia Pacific and Improving Access to Evidence-Based Medical Treatments for Mental Health 2021-08-02 10:25
Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma 2021-08-02 07:29
Rey Announces $10 Million in New Series A Funding to Expand Access to Mental Health through Digital Capabilities 2021-07-31 02:56
1 364 365 366 367 368 895